Marizyme
Davenport, US
Biotech
Founders & leadership
TB
Terry BrostowinDirector
JS
James SapirsteinExecutive Officer, Director
ND
Nicholas DeVitoExecutive Officer
Reported raises · per SEC filings
Form D private placements$1MraisedMay 2023 · 1 investors · Biotechnology
Rule 506(b)$265.2KraisedMay 2023 · 4 investors · Biotechnology
Rule 506(b)$1.2MraisedNov 2021 · 4 investors · Biotechnology
Rule 506(b)$1.2MraisedOct 2021 · 4 investors · Biotechnology
Rule 506(b)$5.6MraisedAug 2020 · 22 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.